Virtual MACS® COVID-19 Day

Explore the latest findings about SARS-CoV-2 research and join in discussions at our  
Virtual MACS® COVID-19 Day

September 23, 2020 | 9:00 a.m.– 4:30 p.m. CEST


During these challenging times of the COVID-19 pandemic, many researchers have joined forces to uncover the pathogenesis of SARS-CoV-2 and find targets for therapies or a preventive vaccine.

To give you an insight into the latest discoveries on SARS-CoV-2 and promote scientific networking, we will host a virtual event full of interesting talks and round table discussions with several experts who will outline their latest findings in COVID-19 research. 

You will also have the opportunity to network with the other virtual attendees and Miltenyi Biotec specialists.

The event is free of charge. Register by completing the form below.

Program of virtual meeting

Tentative agenda

Virtual MACS® COVID-19 Day 

9:00 a.m.Welcome and introduction
Dr. Cristina Conforti Andreoni, Miltenyi Biotec.
9:30 a.m.Cytokine Capture System for SARS-CoV-2 specific T cells 
Prof. Leung Wing Hang – KK Women’s and Children’s Hospital, Singapore.
10:00 a.m.The role of C5a-C5aR1 in COVID-19
Prof. Eric Vivier – Chief Scientific Officer, Innate Pharma. Professor of Immunology, Aix Marseille Université, France.
10:30 a.m.Roundtable discussion 1
11:00 a.m.Deep profiling of SARS-CoV-2-specific T cells from healthy donors and COVID-19 patients using ARTE
Professor Alexander Scheffold – 
Institute of Immunology, Christian-Albrechts-Universität zu Kiel, Germany.
11:30 a.m.Networking sessions 1
12:00 p.m.Lunch break
1:00 p.m.SARS-CoV-2 proteins and analysis of humoral immunity in COVID-19 patients
Dr. Susanne Bethke – Global Product Manager, Miltenyi Biotec.
1:30 p.m.Innate immunity against SARS-CoV-2 
Prof. Andrea Cossarizza – Department of Medical and Surgical Sciences for Children and Adults, 
University of Modena and Reggio Emilia School of Medicine, Italy. 
2:00 p.m.Treg cell therapy as a new approach to prevent the immune hyperactivation responsible for the clinical 
worsening of COVID-19
Prof. Rafael Correa Rocha – Head of Laboratory, Instituto de Investigación Sanitaria Gregorio Marañón (IISGM), Spain
2:30 p.m.Networking sessions 2
3:00 p.m.The signature of antiviral T cell immunity in COVID-19 patients and healthy controls: 
Analysis of frequency, specificity, functionality and phenotype in the course of disease and recovery 
Prof. Britta Eiz-Vesper – Institute for Transfusion Medicine and Transplant Engineering, alloCELL Labor and T cell 
donation register, Medical School Hanover), Germany.
3:30 p.m.Roundtable discussion 2
4:00 p.m.Special topic: Working safely during the COVID-19 pandemic
David Leclerc –SCYM(ASCP) Technical Director, Cytometry Antibody Technologies Facility, The University of Chicago, USA.
4:30 p.m.Closing

Check back soon for final agenda and confirmed speakers.

 Virtual event platform

Please take a look at the technical information of the virtual event platform below:

  • The live event will be hosted on Microsoft Teams, an active internet connection is required.
  • It is not neccesary to download Microsoft Teams software or apps to access the meeting. A browser option will also be available. We will send you a link to access the meeting 48 hours prior to the event.
  • Please check that your device system and navigation browser are compatible with Microsoft Teams.
  • For more information about Microsoft Teams, click here.

Registration form

Please select your interests*:

Participant information

General Information

Detailed Information

Please give your details for further inquiries.

* Mandatory field

Questions / Comments